XML 28 R63.htm IDEA: XBRL DOCUMENT v3.20.1
Related party transactions (Narrative) (Details)
12 Months Ended
Nov. 04, 2019
CAD ($)
$ / shares
shares
Dec. 31, 2019
CAD ($)
Share
Dec. 31, 2018
CAD ($)
Disclosure of transactions between related parties [line items]      
Key management personnel compensation   $ 17,312,577 $ 5,029,516
Amount of bonus   4,836,192 1,814,115
Consulting fees expenses   2,288,129 2,037,049
Directors' remuneration expense   203,521 66,667
Director's remuneration payable   98,521  
Share-based payments expense   12,476,385 $ 3,215,401
Class B shares      
Disclosure of transactions between related parties [line items]      
Number of shares issued in private placement | shares 228,670    
Share issue price per share | $ / shares $ 20.10    
Value of shares issued in private placement $ 4,598,618    
Former President and CEO      
Disclosure of transactions between related parties [line items]      
Key management personnel compensation   96,250  
Former CEO      
Disclosure of transactions between related parties [line items]      
Other allowances   4,500  
Chief Executive Officer      
Disclosure of transactions between related parties [line items]      
Payment of expenses   754,311  
Trade and other payables   95,708  
Chief Executive Officer | Class B shares      
Disclosure of transactions between related parties [line items]      
Amount of bonus   $ 1,428,591  
Number of share issued for share-based bonus expense | Share   200,927  
President      
Disclosure of transactions between related parties [line items]      
Share-based payments expense   $ 132,178  
President of FSD | Class B shares      
Disclosure of transactions between related parties [line items]      
Amount of bonus   $ 109,892  
Number of share issued for share-based bonus expense | Share   15,456  
Chief Financial Officer      
Disclosure of transactions between related parties [line items]      
Management fees   $ 196,870  
Chief Operating Consultant      
Disclosure of transactions between related parties [line items]      
Consulting fees expenses   90,000  
Former Chief Operating Officer      
Disclosure of transactions between related parties [line items]      
Consulting fees expenses   16,667  
Independent directors      
Disclosure of transactions between related parties [line items]      
Directors' remuneration expense   40,000  
Additional remuneration as Chairman   10,000  
Officers and Directors | Class B shares      
Disclosure of transactions between related parties [line items]      
Number of shares subscribed | shares 164,755    
FV Pharma Inc | Former President and CEO      
Disclosure of transactions between related parties [line items]      
Key management personnel compensation, retirement benefits   770,000  
Key management personnel compensation   54,958  
FV Pharma Inc | President | Class B shares      
Disclosure of transactions between related parties [line items]      
Amount of bonus   $ 54,946  
Number of share issued for share-based bonus expense | Share   7,728  
FSD Biosciences | President      
Disclosure of transactions between related parties [line items]      
Consulting fees expenses   $ 330,436  
FSD Biosciences | President | Class B shares      
Disclosure of transactions between related parties [line items]      
Amount of bonus   $ 109,892  
Number of share issued for share-based bonus expense | Share   15,456